California voters are being asked to authorize $8.4 billion in borrowing for immunology research, but the proposition’s fine print points straight toward a single UCLA-linked Los Angeles institute backed by wealthy donors who helped put the measure on the ballot. About half of the bond money, $4.2 billion, would go to a designated institute if it meets the eligibility rules, while the rest would be distributed through grants. That is a research investment in theory, and a remarkably specific funding lane in practice.
The nonpartisan Legislative Analyst’s Office says Proposition 38 would cost the state roughly $500 million to $600 million annually for about 20 years. The measure would require treatments developed with bond money to be sold to California residents at a 20% discount, while 10% of revenue from discoveries would first go toward repaying the state.
The Fine Print Looks Surprisingly UCLA-Specific
KPBS reports that the institute receiving the $4.2 billion must be affiliated with a UC campus whose medical center has more than 3.5 million outpatient visits and at least 35,000 inpatient admissions. UCLA is currently the only UC campus that appears to clear both thresholds, with more than 4 million outpatient visits and at least 46,000 inpatient admissions.
The requirements also call for a nonprofit founded before 2025, at least 200,000 square feet of research space, at least $250 million in philanthropic support and two donations of at least $50 million for specified programs. Those details line up neatly with the California Institute for Immunology and Immunotherapy, which is planned as the main scientific tenant at UCLA’s former Westside Pavilion research campus.
UCLA Newsroom says Gary and Alya Michelson committed $120 million to launch the institute, where Gary Michelson serves as board chair. Earlier Hoodline reporting detailed UCLA’s plan to turn the shuttered mall into an approximately 800,000-square-foot research hub anchored by the immunology institute and a quantum science center.
The Backers Say It Is About Science Not A Single Beneficiary
A February filing from the California Secretary of State identifies the campaign behind the measure as Californians for Immunology Research and Cures, sponsored by the Michelson Center for Public Policy. The campaign’s leading funders are listed as Gary K. Michelson and affiliated entities, along with Meyer Luskin, another institute co-founder.
KPBS reports that Michelson and the Michelson Center for Public Policy donated at least $8.2 million to the Yes on Proposition 38 campaign, while Luskin gave at least $5 million. Campaign spokesperson Claudia Briggs says the criteria were designed to ensure that whichever institute is selected already has the facilities, funding and university relationships needed to move quickly.
The Other $4.2 Billion Still Comes With Strings
Proposition 38 would not simply create a blank-check grant pool for every California university. The grant council would include representatives from seven UC campuses and other universities and nonprofits, and proposals would have to focus specifically on immunology and immunotherapy.
The institute receiving the first half of the bond money would also confer with the council on final grant decisions, while winning researchers would have to maintain a close relationship with that institute and offer it an opportunity to participate in related clinical trials. That gives the UCLA-linked center more than a financial stake in the proposition; it could also gain influence over how the other half is spent.
That is why the word giveaway keeps surfacing, even though the measure would fund real scientific work and could produce meaningful treatments. The concern is less that Los Angeles should not host a major research center than that California voters are being asked to approve a statewide debt package whose eligibility rules appear to have been written around one local institution.
What California Voters Are Actually Choosing
Proposition 38 will appear on the November 3, 2026, ballot. A yes vote would authorize a huge public investment in immunology research, but it would also lock in a structure that sends roughly half the money to an unnamed institute that currently looks a lot like UCLA’s California Institute for Immunology and Immunotherapy.
The cures may be worth betting on. The cleaner question for voters is whether the state should borrow billions through a broadly worded ballot measure that seems to know exactly where much of the money is headed.
